Jeigu esate nėščia, žindote kūdikį, manote, kad galbūt esate nėščia, arba planuojate pastoti, tai prieš vartodama šį vaistą, pasitarkite su gydytoju arba vaistininku. Endocarditis:Using conventional amphotericin B: If needed, test dose of 1 mg infused over 20-30 minutes. 0.6-1 mg/kg/day for 1 wk, then 0.8 mg/kg/day every other day for 6-8 wk post-operatively.

prurit (mâncărime la nivelul pielii). Dacă observaţi oricare dintre aceste reacţii adverse, în special reacţii alergice (de hipersensibilitate), întrerupeţi administrarea Essentiale Forte şi adresaţi-vă medicului dumneavoastră, care va evalua severitatea manifestărilor pe care le prezentaţi şi va decide măsurile necesare. The total safety data base is composed of 921 patients treated with Essentiale Forte® (amphotericin b) (5 patients were enrolled twice and counted as separate patients), of whom 775 were treated with 5 mg/kg/day. Of these 775 patients, 194 patients were treated in four comparative studies; 25 were treated in open-label, non-comparative studies; and 556 patients were treated in an open-label, emergency-use program. Most had underlying hematologic neoplasms, and many were receiving multiple concomitant medications. Of the 556 patients treated with Essentiale Forte® (amphotericin b) , 9% discontinued treatment due to adverse events regardless of presumed relationship to study drug. List of excipients: Ethanol 96%, hard fat, soya-bean oil (Ph. Eur.), hydrogenated castor oil, ethyl vanillin,Treatment of Cryptococcal Meningitis in HIV infected patients (see Description Of Clinical Studies). Aspergillosis,Aspergilloma, Blastomycosis, Histoplasmosis, Fungal Infection, Zygomycosis, Infection, Candidiasis,Vaginal, Cryptococcal Meningitis, Cryptococcosis, Leishmaniasis, Meningitis, Sporotrichosis, Fusariosis Povremeno (mogu da se jave kod najviše 1 na 100 pacijenata koji uzimaju lek): digestivni poremećaji Ako neko od neželjenih dejstava postane ozbiljno ili ako uočite neželjena dejstva koja nisu navedena u

Deoarece nu au fost efectuate studii clinice specifice cu Essentiale Forte, acest medicament nu trebuie utilizat la copii cu varsta sub 12 ani. The following adverse events also have been reported in 2% to 10% of Essentiale Forte-treated patients receiving chemotherapy or bone marrow transplantation, or had HIV disease in six comparative, clinical trials: Body as a WholeReacţii adverse foarte rare (pot afecta până la 1 din 10000 persoane): reacţii alergice la nivelul pielii, cum sunt exantemul sau erupţia cutanată şi urticaria. Infusion related reactions (such as chills and pyrexia) recorded following the administration of Abelcet have generally been mild or moderate, and have mainly be recorded during the first 2 days of administration. In cazul in care urmati un tratament cu anticoagulante, va rugam sa va adresati medicului inainte de a lua Essentiale Forte. The pharmacokinetics of amphotericin B after the administration of Essentiale Forte® (amphotericin b) are nonlinear. Volume of distribution and clearance from blood increase with increasing dose of Essentiale Forte® (amphotericin b) , resulting in less than proportional increases in blood concentrations of amphotericin B over a dose range of 0.6-5 mg/kg/day. The pharmacokinetics of amphotericin B in whole blood after the administration of Essentiale Forte® and amphotericin B desoxycholate are: daca sunteti alergic la preparate din seminte de soia sau la oricare dintre celelalte componente ale acestui medicament (enumerate la punctul 6).